Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
10 hedge funds and large institutions have $1.51M invested in Novo Integrated Sciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
292% more capital invested
Capital invested by funds: $386K → $1.51M (+$1.13M)
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
67% more funds holding
Funds holding: 6 → 10 (+4)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$638K |
| 2 |
Morgan Stanley
New York
|
+$286K |
| 3 |
Renaissance Technologies
New York
|
+$121K |
| 4 |
Millennium Management
New York
|
+$110K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$49.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$41K |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$29K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.42K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $642K | +$638K | +25,594 | New |
|
|
2
Morgan Stanley
New York
| $288K | +$286K | +11,467 | New |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $218K | +$3.59K | +144 | +2% |
|
|
4
Renaissance Technologies
New York
| $122K | +$121K | +4,863 | New |
|
|
5
Millennium Management
New York
| $111K | +$110K | +4,435 | New |
|
6
BlackRock
New York
| $50K | +$48.9K | +1,963 | New |
|
|
7
Geode Capital Management
Boston,
Massachusetts
| $49K | +$49.5K | +1,986 | New |
|
8
Citadel Advisors
Miami,
Florida
| $30K | +$29.4K | +1,179 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $3K | -$2.42K | -97 | -49% |
|
|
10
Goldman Sachs
New York
| – | -$41K | -1,172 | Closed |
|
|
MS
11
Maven Securities
St Helier,
Jersey
| – | -$29K | -834 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$9K | -254 | Closed |
|
|
13
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -20 | Closed |
|
14
Wells Fargo
San Francisco,
California
| – | +$125 | +5 | New |
|
NVOS Hedge Fund Activity: Q2 2021 in Review
10 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q2 2021, worth a combined $1.51M — up 292% from $386K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NVOS positions and 4 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $638K. The largest seller was Goldman Sachs, exiting entirely with an estimated $41K sold.
- 10 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q2 2021, up from 6 in Q1 2021.
- Funds reported $1.51M of Novo Integrated Sciences, Inc. Common Stock stock for Q2 2021, up 292% quarter-over-quarter.
- 8 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q2 2021 and 4 closed out, a net change of +4 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $638K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q2 2021 was Goldman Sachs, an estimated $41K sold.
Based on aggregated 13F filings for Q2 2021.